JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258963

Human MKRN1 knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

MKRN1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 1 and 30 bp deletion in exon 1 and 3 bp deletion in exon 1 and 5 bp deletion in exon 1.
4 Images
Sanger Sequencing - Human MKRN1 knockout HEK-293T cell lysate (AB258963)
  • Sanger seq

Unknown

Sanger Sequencing - Human MKRN1 knockout HEK-293T cell lysate (AB258963)

Allele-4 : 2 bp deletion in exon 1

Sanger Sequencing - Human MKRN1 knockout HEK-293T cell lysate (AB258963)
  • Sanger seq

Unknown

Sanger Sequencing - Human MKRN1 knockout HEK-293T cell lysate (AB258963)

Allele-3 : 3 bp deletion in exon 1

Sanger Sequencing - Human MKRN1 knockout HEK-293T cell lysate (AB258963)
  • Sanger seq

Unknown

Sanger Sequencing - Human MKRN1 knockout HEK-293T cell lysate (AB258963)

Allele-1 : 30 bp deletion in exon 1

Sanger Sequencing - Human MKRN1 knockout HEK-293T cell lysate (AB258963)
  • Sanger seq

Unknown

Sanger Sequencing - Human MKRN1 knockout HEK-293T cell lysate (AB258963)

Allele-2 : 5 bp deletion in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 1 and 30 bp deletion in exon 1 and 3 bp deletion in exon 1 and 5 bp deletion in exon 1.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258963-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human MKRN1 knockout HEK293T cell lysate", "number":"AB258963-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258963-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
MKRN1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MKRN1 also known as Makorin-1 is a protein that functions as an E3 ubiquitin ligase. This protein has a molecular mass of approximately 58-60 kDa. It is highly expressed in human tissues including the brain heart and skeletal muscle. MKRN1 contains distinct zinc finger motifs that allow it to tether to its substrates aiding in target protein modification and degradation.
Biological function summary

MKRN1 regulates protein stability and turnover within cells. It plays a significant role in controlling gene expression through ubiquitination processes. MKRN1 does not form part of larger protein complexes but interacts individually with its targets. Researchers study its impact on the transcriptional activities of specific proteins given its ability to tag substrates for proteasomal degradation.

Pathways

MKRN1 participates in key cellular pathways such as cell cycle regulation and apoptosis. It interacts with proteins like p53 and ribosomal protein L6 influencing these pathways. Its ubiquitin ligase function connects it to various cellular control mechanisms essential for maintaining homeostasis and responding to cellular stressors.

Researchers established a connection between MKRN1 and cancer specifically prostate cancer. Its regulation of p53 activity influences tumor growth and cell death. Additionally studies show links between MKRN1 and neurodegenerative disorders implicating its role in protein aggregation and neuron survival. MKRN1's interaction with key proteins such as p53 and neuronal factors highlights its potential as a therapeutic target in these diseases.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com